Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$156.0 - $265.78 $541,476 - $922,522
-3,471 Closed
0 $0
Q3 2021

Nov 02, 2021

SELL
$228.69 - $274.2 $150,020 - $179,875
-656 Reduced 15.9%
3,471 $897,000
Q2 2021

Aug 03, 2021

BUY
$169.89 - $231.37 $246,340 - $335,486
1,450 Added 54.17%
4,127 $948,000
Q1 2021

May 11, 2021

BUY
$143.93 - $207.3 $385,300 - $554,942
2,677 New
2,677 $451,000

Others Institutions Holding HSKA

About HESKA CORP


  • Ticker HSKA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 10,818,900
  • Description
  • Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...
More about HSKA
Track This Portfolio

Track Waratah Capital Advisors Ltd. Portfolio

Follow Waratah Capital Advisors Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waratah Capital Advisors Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Waratah Capital Advisors Ltd. with notifications on news.